Dexus Bulks Up Healthcare Portfolio with Bragg Centre Buy


Listed office REIT Dexus is making a significant push into healthcare property, picking up the Australian Bragg Centre for $446.2 million.

The buy is one of the largest single-asset private healthcare acquisitions to date, and pushes Dexus’ exposure to healthcare over the $1 billion mark.

Dexus head of healthcare partnerships George Websdale, who is speaking at The Urban Developer’s upcoming Healthcare Property vSummit, said the group is positioning itself as a key institutional partner in Australian healthcare property.

“This acquisition is a great example where private capital and specialised real estate expertise can unlock complex health investments,” Websdale said.

Websdale will round out a panel with Centuria Healthcare’s managing director Andrew Hemming and Barwon head of healthcare property Tom Patrick.

The Bragg Centre, developed by Adelaide firm Commercial & General, is Australia’s first and only proton therapy cancer treatment facility. It is expected to treat its first patients 18 months from its August 2023 completion date.

Related: ‘Healing Architecture’ Aids Healthcare Development

The building sits within Adelaide’s $3.6 billion BioMed City precinct, and is 77 per cent pre-leased with an average weighted average lease expiry of 21.9 years from completion.

Commercial & General chief executive Trevor Cooke said the acquisition marks a vote of confidence by the institutional market in the sector and the South Australian economy.

Dexus acquired the Bragg Centre in a 50:50 venture with its unlisted Healthcare Wholesale Property Fund.

Dexus’ unlisted healthcare fund was initially seeded in 2017 by $370 million in assets including the Calvary Adelaide Hospital—also developed by Commercial & General—and the GP Plus Healthcare Centre in Elizabeth, north of Adelaide.

Buoyed by $70 million of institutional investment it attracted earlier this year, the fund picked up the College Junction building in Brisbane’s Clayfield for $36.5 million.

Dexus boss Darren Steinberg said the buy increases the group’s exposure to a sector with strong tailwinds.

“This transaction accelerates the growth of our funds management platform and is a step towards our goal of being a partner of choice in Australian healthcare property.”

The transaction is due to settle 30 October 2020.


To register for this upcoming event, click here.

Show Comments
advertise with us
The Urban Developer is Australia’s largest, most engaged and fastest growing community of property developers and urban development professionals. Connect your business with business and reach out to our partnerships team today.
Article originally posted at: